TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
VTR

Ventas Inc

Real Estate · REIT - Healthcare Facilities

87.70$ -0.6% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Ratios

Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.

Tick rows to compare them in a chart (up to 4)

Ratios VTR
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Valuation
39.2 45.1 33.5 15.9 51.4 49.3 42.0 402.8 302.2 142.4
6.1 5.7 6.3 6.0 5.6 5.5 4.9 5.2 4.1 4.5 5.0 6.1
2.1 2.0 2.1 2.0 2.0 2.0 1.8 1.8 1.7 2.1 2.3 2.9
9.9 9.2 9.5 9.3 8.7 8.8 7.9 8.3 7.1 7.4 7.5 8.2
17.8 16.6 16.8 17.1 18.1 18.0 15.5 18.6 18.2 17.0 19.2 21.5
17.6 14.7 17.4 16.5 16.1 24.3 20.0 33.3 25.3 21.6 23.2 27.2
5.7% 6.8% 5.7% 6.1% 6.2% 4.1% 5.0% 3.0% 4.0% 4.6% 4.3% 3.7%
Margins
60.6% 57.1% 58.1% 58.4% 54.8% 53.2% 48.9% 45.4% 44.7% 43.1% 42.6% -5.9%
28.5% 25.4% 16.2% 17.4% 23.0% 22.2% 15.6% 11.0% 11.7% 9.2% 13.8% 14.2%
15.5% 12.7% 18.9% 38.0% 10.9% 11.2% 11.6% 1.3% -1.1% -0.9% 1.6% 4.3%
34.5% 39.1% 36.3% 36.4% 34.9% 22.6% 24.3% 15.5% 16.1% 20.8% 21.5% 22.6%
Returns
5.4% 4.3% 6.2% 12.4% 4.0% 4.1% 4.3% 0.4% -0.5% -0.4% 0.8% 2.0%
2.2% 1.9% 2.8% 5.7% 1.8% 1.8% 1.8% 0.2% -0.2% -0.2% 0.3% 0.9%
Balance Sheet & Debt
11,752 11,335 10,987 11,733 11,518 12,901 11,676 12,214 12,602 12,982 12,625 12,270
6.9 6.2 5.6 6.0 6.4 6.8 6.0 7.1 7.8 6.7 6.5 5.5
41.2% 43.2% 45.4% 45.6% 45.5% 42.7% 42.5% 44.3% 42.0% 38.4% 41.1% 45.4%
1.3 1.2 1.1 1.1 1.1 1.2 1.2 1.1 1.3 1.4 1.3 1.0
Per Share
1.60 1.25 1.86 3.78 1.14 1.17 1.17 0.13 -0.13 -0.10 0.19 0.54
10.37 9.84 9.88 9.97 10.43 10.47 10.08 9.91 11.06 11.09 11.83 12.61
29.51 28.82 30.22 30.49 28.59 28.51 27.04 28.33 27.19 23.39 25.87 27.08
3.57 3.85 3.59 3.63 3.64 2.37 2.45 1.54 1.78 2.31 2.54 2.85

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?